Boothbay Fund Management’s Nuvation Bio NUVB Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $366K | Hold |
187,603
| – | – | 0.01% | 850 |
|
2025
Q1 | $330K | Buy |
187,603
+166,593
| +793% | +$293K | 0.01% | 872 |
|
2024
Q4 | $55.9K | Buy |
21,010
+125
| +0.6% | +$333 | ﹤0.01% | 1182 |
|
2024
Q3 | $47.8K | Sell |
20,885
-68,964
| -77% | -$158K | ﹤0.01% | 1315 |
|
2024
Q2 | $262K | Sell |
89,849
-68,965
| -43% | -$201K | 0.01% | 1053 |
|
2024
Q1 | $578K | Sell |
158,814
-102,576
| -39% | -$373K | 0.01% | 822 |
|
2023
Q4 | $395K | Hold |
261,390
| – | – | 0.01% | 938 |
|
2023
Q3 | $350K | Buy |
+261,390
| New | +$350K | 0.01% | 1014 |
|
2022
Q2 | – | Sell |
-22,640
| Closed | -$119K | – | 2205 |
|
2022
Q1 | $119K | Hold |
22,640
| – | – | ﹤0.01% | 1673 |
|
2021
Q4 | $192K | Buy |
+22,640
| New | +$192K | ﹤0.01% | 1338 |
|
2021
Q2 | – | Sell |
-49,635
| Closed | -$519K | – | 1844 |
|
2021
Q1 | $519K | Buy |
49,635
+28,147
| +131% | +$294K | 0.02% | 750 |
|
2020
Q4 | $251K | Buy |
+21,488
| New | +$251K | 0.01% | 858 |
|